| 000 | 01437 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516235334.0 | ||
| 264 | 0 | _c20150908 | |
| 008 | 201509s 0 0 chi d | ||
| 022 | _a1672-173X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHu, Yuan | |
| 245 | 0 | 0 |
_a[Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma]. _h[electronic resource] |
| 260 |
_bSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition _cJul 2014 |
||
| 300 |
_a680-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aZhao, Xia | |
| 700 | 1 | _aWu, Li-Li | |
| 700 | 1 | _aCai, Chang-Ping | |
| 700 | 1 | _aZhao, Wei-Li | |
| 700 | 1 | _aWang, Li | |
| 773 | 0 |
_tSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition _gvol. 45 _gno. 4 _gp. 680-4 |
|
| 999 |
_c24252230 _d24252230 |
||